home ventilation masthead

See clearly. Treat optimally.

Philips coronary solutions give you the visualization needed to quickly and precisely assess complex PCI challenges so you can treat optimally with Philips therapeutic solutions.

Need more information on complex PCI?
Need more information on complex PCI?
*

Contact information

* This field is mandatory
*
*
*
*
*
*
*
*
*
By specifying your reason for contact we will be able to provide you with a better service.
We work with partners and distributors who may contact you about this Philips product on our behalf.
*
*

Final CEE consent

Complex PCI cases are becoming more common, leading to an increased risk of adverse events.1
 

Clear procedural guidance and optimal vessel preparation can help you achieve better outcomes. Explore the different challenges seen in complex PCI cases and how Philips’ specialty tools can help you.

Resistant or restenotic lesions


Resistant and restenotic lesions exhibit characteristics making them challenging to dilate and treat with conventional tools. Learn more about how our products, ELCA coronary laser atherectomy catheter, AngioSculpt Evo Rx PTCA scoring balloon catheter and IVUS imaging help you achieve optimal results in your treatment decisions.

Anatomically complex lesions


Anatomically complex lesions exhibit challenging characteristics complicating visualization, crossing and treatment planning. Learn the challenges of treating anatomically complex lesions and how our products ELCA coronary laser atherectomy, AngioSculpt Evo Rx PTCA scoring balloon catheter and IVUS imaging may assist in treatment.

Plan, land and expand stents optimally

Dr. Jimmy Kerrigan optimizes stents with IVUS
Learn how Dr. Kerrigan defines stent optimization
Enable improved outcomes and fewer complications. The treatment of coronary lesions with DES is complicated by the challenges of suboptimal post stent results, such as stent under expansion, incomplete stent apposition, edge dissection and geographic miss, which may contribute to increased risk of stent failure. 
Vessel stent graphic

Physician and product videos


Enable improved outcomes and fewer complications. The treatment of coronary lesions with DES is complicated by the challenges of suboptimal post stent results, such as stent under expansion, incomplete stent apposition, edge dissection and geographic miss, which may contribute to increased risk of stent failure.
Professionals discussing use of iFR
Use of iFR and IVUS Co-Registration to simplify PCI decision-making
Expert discussing how laser atherectomy works
How does laser atherectomy actually work?
Graphic of AngioSculpt Evo
New AngioSculpt Evo - see the power and safety of a scoring balloon

Advanced physiologic guidance, imaging and vessel prep for PCI planning

IntraSight product image
Multiple modalities (iFR, FFR, IVUS) on a single platform.
IntraSight Interface
Multiple modalities (iFR, FFR, IVUS) on a single platform.
IntraSight interface with diameter measurements
Provides area/diameter measurements for accurate stent sizing.
OmniWire
Solid core workhorse design for flexibility.
AngioSculpt Evo RX PTCA scoring balloon catheter
Highly deliverable scoring balloon, with the power to safely dilate resistant lesions.1,2,3
ELCA coronary laser atherectomy catheter
Indicated for occluded saphenous vein, ostial lesions, moderately calcified stenosis, total occlusions, and more.

IVUS apps designed for interventional cardiologists

Tablet with IVUS
Check out the IVUS App for interactive workflow and image interpretation practice
Cardio Ex on mobile
Learn IVUS virtually with the Cardio Ex app
Philips Elite Academy logo

Philips ELIITE Academy is focused on delivering high value and real-time strategic educational programs that meet the evolving needs of our customers.


To initiate your clinical pathway or register for one our cardiovascular US medical educational programs, please contact your local Philips representative.


For more information on the available courses, please visit www.philipseliiteacademy.com.

  1. Costa JR, Mintz GS, Carlier SG, et al. Nonrandomized comparison of coronary stenting under intravascular ultrasound guidance of direct stenting without predilation versus conventional predilation with a semi-compliant balloon versus predilation with a new scoring balloon. Am J Cardiol. 2007;100:812-817.
  2. Costa RA, Mooney MR, Teirstein PS, et al. Final results from the multi-center trial of the angiosculpt scoring balloon catheter for the treatment of complex coronary artery lesions Cardiovascular Revascularization Medicine 7 (2006)81–126.
  3. AngioSculpt Test Report SR-1571 (2008).


ELCA important safety information Indications:
The laser catheters are intended for use either as a stand-alone modality or in conjunction with percutaneous transluminal coronary balloon angioplasty (PTCA) in patients who are acceptable candidates for coronary artery bypass graft (CABG) surgery. The following indications for use, contraindications and warnings have been established through multicenter clinical trials. The Philips CVX-300 Excimer laser system and the multi-fiber laser catheter models are safe and effective for the following indications: occluded saphenous vein bypass grafts, ostial lesions, long lesions (greater than 20mm in length), moderately calcified stenosis, total occlusions traversable by a guidewire, lesions which previously failed balloon angioplasty, restenosis in 316L stainless steel stents, prior to the administration of intravascular brachytherapy. These lesions must be traversable by a guidewire and composed of atherosclerotic plaque and/or calcified material. The lesions should be well defined by angiography. Contraindications: Lesion is in an unprotected left main artery. Lesion is beyond acute bends or is in a location within the coronary anatomy where the catheter cannot traverse. Guidewire cannot be passed through the lesion. Lesion is located within a bifurcation. Patient is not an acceptable candidate for bypass graft surgery. Potential adverse events: Use of the Philips CVX-300 Excimer laser system may contribute to the following complications: dissection of the arterial wall, perforation, acute reclosure, embolization, aneurysm formation, spasm, coronary artery bypass graft surgery, thrombus, myocardial infarction, arrhythmia, filling defects, death. No long term adverse effects of ELCA are known at this time. Risks: The primary endpoint defined in the laser angioplasty of restenosis stents (LARS) randomized trial was the absence of major adverse cardiac events (MACE) at 6 months: Death; myocardial infarction; coronary artery bypass surgery. Procedural complications include: any dissection, acute thrombus, haziness, no reflow, arrhythmia, acute vessel closure, occlusion of side branch, occlusion non-target, coronary spasm, coronary embolism, coronary perforation, laser/stent damage, balloon/stent damage, and other serious. Caution: Federal law restricts this device to sale by or on the order of a physician.
 

Summary of safety and effectiveness – PTCA catheter AngioSculpt Evo PTCA important safety information
 

The AngioSculpt Evo scoring balloon catheter is indicated for use in the treatment of hemodynamically significant coronary artery stenosis, including in-stent restenosis and complex type C lesions, for the purpose of improving myocardial perfusion.
 

The AngioSculpt Evo catheter should not be used for coronary artery lesions unsuitable for treatment by percutaneous revascularization, and coronary artery spasm in the absence of a significant stenosis. Possible adverse effects include, but are not limited to: death; heart attack (acute myocardial infarction); embolism, total occlusion of the treated coronary artery; coronary artery dissection, perforation, rupture, or injury; pericardial tamponade; no/slow reflow of treated vessel; emergency coronary artery bypass (CABG); emergency percutaneous coronary intervention; CVA/stroke/ embolic stroke; pseudoaneurysm; restenosis of the dilated vessel; unstable angina; thromboembolism or retained device components; irregular heart rhythm (arrhythmias, including life-threatening ventricular arrhythmias); severe low (hypotension)/high (hypertension) blood pressure; coronary artery spasm; hemorrhage or hematoma; need for blood transfusion; surgical repair of vascular access site; creation of a pathway for blood flow between the artery and the vein in the groin (arteriovenous fistula); drug reactions, allergic reactions to x-ray dye (contrast medium); and infection. This information is not intended to replace a discussion with your healthcare provider on the benefits and risks of this procedure to you.

 

Caution: Federal law restricts this device to sale by or on the order of a physician.

 

 ©2021 Koninklijke Philips N.V. All rights reserved. Approved for external distribution. D059578-00 032021